Insulin resistance, often induced by obesity, is the underlying abnormality for type 2 … Announcement, Blogs, Diabetes biobank, Diabetes check, patient care & research March 5, 2025 RAJLAXMI Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes
the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) … Diabetes check, FDA Approval, Global Pharma News, insulin therapy February 15, 2025 JYOTI FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
1The U.S. Food and Drug Administration (FDA) is alerting patients who use diabetes devices and … Announcement, Diabetes check, FDA warning, Global Pharma News, Smartphone Device Alert Settings February 12, 2025 JYOTI FDA Alerts Patients to Regularly Check Diabetes-Related Smartphone Device Alert Settings, Especially Following Phone Hardware or Software Changes